(Q35651435)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

review article

1 reference

title

A porous defense: the leaky epithelial barrier in intestinal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

author name string

Le Shen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Jerrold R Turner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

page(s)

282-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14767487%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.3700050

18 November 2019

exact match

0 references

cites work

The burden of selected digestive diseases in the United States.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal permeability in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal permeability and the prediction of relapse in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Abnormal intestinal permeability predicts relapse in inactive Crohn disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Clustering of increased small intestinal permeability in families with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal permeability in patients with Crohn's disease and their first degree relatives

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin- and myosin-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal permeability in children with Crohn's disease and coeliac disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal permeability after single dose gluten challenge in coeliac disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal permeability assessed with polyethylene glycols in children with diarrhea due to rotavirus and common bacterial pathogens in a developing community.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Acute infections with Giardia lamblia and rotavirus decrease intestinal permeability to low-molecular weight polyethylene glycols (PEG 400).

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Giardia lamblia disrupts tight junctional ZO-1 and increases permeability in non-transformed human small intestinal epithelial monolayers: effects of epidermal growth factor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intercellular bridges

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Junctional complexes in various epithelia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

The ultrastructure of Brunner's glands of the cat

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Evidence for the lipidic nature of tight junction strands

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Standing-gradient osmotic flow. A mechanism for coupling of water and solute transport in epithelia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Biological Membranes: The Physical Basis of Ion and Nonelectrolyte Selectivity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Morphological factors influencing transepithelial permeability: A model for the resistance of theZonula Occludens

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Occludin: a novel integral membrane protein localizing at tight junctions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Cingulin, a new peripheral component of tight junctions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

'Putting the squeeze' on the tight junction: understanding cytoskeletal regulation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Intestinal glucose transport using perfused rat jejunum in vivo: model analysis and derivation of corrected kinetic constants.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Noninvasive in vivo analysis of human small intestinal paracellular absorption: regulation by Na+-glucose cotransport

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Regulation of human jejunal transmucosal resistance and MLC phosphorylation by Na(+)-glucose cotransport

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Transepithelial resistance can be regulated by the intestinal brush-border Na(+)/H(+) exchanger NHE3.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Show me the pathway! Regulation of paracellular permeability by Na(+)-glucose cotransport

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Animal models of inflammatory bowel disease: an overview

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

INFLIXIMAB DOWNREGULATES INTERFERON-γ PRODUCTION IN ACTIVATED GUT T-LYMPHOCYTES FROM PATIENTS WITH CROHN'S DISEASE

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Increased colonic permeability in patients with ulcerative colitis: an in vitro study.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Infliximab in the treatment of medically refractory indeterminate colitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Serum levels and receptor expression of tumor necrosis factor-alpha following human allogeneic and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Infliximab for steroid‐refractory acute GVHD: A case series

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

New developments in the prophylaxis and treatment of graft versus host disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Cytokine profile in coeliac disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Successful infliximab treatment for steroid-refractory celiac disease: a case report

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Effect of temperature on myosin phosphorylation in mouse skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021

Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700050

7 January 2021